🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.8663
-0.0137 (-1.56%)
At close: Nov 20, 2026, 4:00 PM EST
0.9000
+0.0337 (3.89%)
After-hours: Nov 20, 2026, 4:10 PM EST

ABVC BioPharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
--0.510.150.970.36
Revenue Growth
--234.31%-84.28%172.57%-26.34%
Cost of Revenue
--00.30.290.01
Gross Profit
--0.51-0.150.680.35
Selling, General & Admin
2.422.892.265.376.075.75
Research & Development
0.10.120.181.062.691
Operating Expenses
5.797.155.216.6215.812.06
Operating Income
-5.79-7.15-4.71-6.77-15.11-11.71
Interest Expense
-0.17-0.42-0.83-1.31-0.29-0.23
Interest & Investment Income
0.090.170.090.190.190.04
Currency Exchange Gain (Loss)
-0.13-0.08-0.030.02-0.260.43
Other Non Operating Income (Expenses)
00.120.180.070.080.16
EBT Excluding Unusual Items
-5.91-7.36-5.29-7.8-15.4-11.3
Gain (Loss) on Sale of Investments
-1-1-0.34-0.22-0.01-0.27
Asset Writedown
-----0.11-
Other Unusual Items
--0.26--0.36
Pretax Income
-6.91-8.35-5.37-8.02-15.51-11.21
Income Tax Expense
-0.02-0.110.260.80.83
Earnings From Continuing Operations
-6.91-8.38-5.26-8.28-16.31-12.04
Minority Interest in Earnings
2.990.470.360.49-0.11-0.8
Net Income
-3.91-7.91-4.9-7.79-16.42-12.84
Net Income to Common
-3.91-7.91-4.9-7.79-16.42-12.84
Net Income Growth
------
Shares Outstanding (Basic)
262012433
Shares Outstanding (Diluted)
262012433
Shares Change
49.35%72.25%169.26%36.92%26.39%27.07%
EPS (Basic)
-0.15-0.39-0.42-1.80-5.19-5.12
EPS (Diluted)
-0.15-0.39-0.42-1.80-5.19-5.12
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2.17-2.99-1.81-4.21-7.52-7.62
Free Cash Flow Per Share
-0.08-0.15-0.15-0.97-2.37-3.04
Gross Margin
--99.85%-98.15%70.47%98.57%
Operating Margin
---923.34%-4439.24%-1558.54%-3290.07%
Profit Margin
---962.12%-5109.26%-1693.50%-3608.47%
Free Cash Flow Margin
---355.02%-2760.64%-775.23%-2140.33%
EBITDA
-5.77-7.13-4.67-6.74-15.09-11.69
D&A For EBITDA
0.020.030.030.030.020.01
EBIT
-5.79-7.15-4.71-6.77-15.11-11.71
SEC Filings: 10-K · 10-Q